Overall Survival With Palbociclib And Fulvestrant in Women With HR+/HER2- ABC: Updated Exploratory Analyses of PALOMA-3, a Double-Blind, Phase 3 Randomized Study

Overview of attention for article published in Clinical Cancer Research, May 2022

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (94th percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

So far, Altmetric has seen 86 X posts from 65 X users, with an upper bound of 324,041 followers.

RT @CCR_AACR: Heading to the workshop Intercepting Molecular Residual Disease in the Clinic #AACR23? You might be interested in this clinic…

Heading to the workshop Intercepting Molecular Residual Disease in the Clinic #AACR23? You might be interested in this clinical trial from Nicholas C. Turner. https://t.co/sbOhHvEUUW @MCristofanill @WeillCornell https://t.co/QIWHeYJDjE

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 82 additional X posts.